| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/30/2014 | CN102292069B 囊泡制剂 Vesicle preparation |
| 07/30/2014 | CN102238940B 含针状活性物质的挤出物 Extrudate containing acicular active substance |
| 07/30/2014 | CN102210689B 包含盐酸伐地那非三水合物的药物 Contains vardenafil hydrochloride trihydrate drug |
| 07/30/2014 | CN102202654B 可咀嚼的缓释制剂 Chewable sustained release formulation |
| 07/30/2014 | CN102188412B 含司来吉兰的粘附制剂 Selegiline-containing adhesive preparation |
| 07/30/2014 | CN102160858B 一种可食用膜及其制作方法 A membrane and its production method edible |
| 07/30/2014 | CN102138892B 甘磷酸胆碱注射制剂及其配制方法和检测方法 Glycerophosphorylcholine injectable formulation and preparation methods and detection methods |
| 07/30/2014 | CN101969929B 粉末状蛋白质组合物及其制备方法 Powdered protein composition and preparation method |
| 07/30/2014 | CN101926782B 一种含地诺孕素的口服固体药物组合物 Containing dienogest oral solid pharmaceutical composition |
| 07/30/2014 | CN101921347B 透明质酸衍生物及含有其的药剂 Hyaluronic acid derivatives and their pharmaceutical agent containing |
| 07/30/2014 | CN101910274B 含紫杉烷的两亲嵌段共聚物胶束组合物及其制备方法 Amphiphilic block copolymer micelle composition and preparation method taxane-containing |
| 07/30/2014 | CN101773466B 一种口服纳米聚合物胶束载药系统及其制备方法 An oral drug nano-polymeric micelle system and its preparation method |
| 07/29/2014 | US8793075 Compositions and methods for therapeutic delivery with frozen particles |
| 07/29/2014 | US8791270 Bendamustine pharmaceutical compositions |
| 07/29/2014 | US8791269 Complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof |
| 07/29/2014 | US8791239 Fibrous assemblies for antibody presentation, and multiplexed antigenic analysis using same |
| 07/29/2014 | US8791174 Ink composition and method of preparing same |
| 07/29/2014 | US8791160 Tranexamic acid formulations |
| 07/29/2014 | US8791154 High concentration olopatadine ophthalmic composition |
| 07/29/2014 | US8791150 Pharmaceutical composition for peroral administration of diindolylmethane |
| 07/29/2014 | US8791127 Mucosal bioadhesive slow release carrier for delivering active principles |
| 07/29/2014 | US8791114 Dihydropyrazoles |
| 07/29/2014 | US8791096 Heat sterilization of glucocorticosteroids |
| 07/29/2014 | US8791093 Pharmaceutical delivery systems for treatment of substance abuse and other addictions |
| 07/29/2014 | US8791076 Agonists of neurotrophin receptors and their use as medicaments |
| 07/29/2014 | US8791064 Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds |
| 07/29/2014 | US8791062 Skin permeating and cell entering (SPACE) peptides and methods of use thereof |
| 07/29/2014 | US8790934 Nanoparticles |
| 07/29/2014 | US8790723 Eutectic-based self-nanoemulsified drug delivery system |
| 07/29/2014 | US8790713 Calcium carbonate granulation |
| 07/29/2014 | US8790709 Polymer Carrier |
| 07/29/2014 | US8790708 Coated tablet formulations and uses thereof |
| 07/29/2014 | US8790704 Combination peptide-nanoparticles and delivery systems incorporating same |
| 07/29/2014 | US8790703 Method for producing preparations of substances poorly soluble in water |
| 07/29/2014 | US8790702 Modified hyaluronic acid polymer compositions and related methods |
| 07/29/2014 | US8790701 Poly-α(1→4)glucopyranose-based matrices with hydrazide crosslinking |
| 07/29/2014 | US8790700 Modified release formulations containing drug-ion exchange resin complexes |
| 07/29/2014 | US8790699 Foam-formed collagen strand |
| 07/29/2014 | US8790698 Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects |
| 07/29/2014 | US8790697 Controlled release delivery system for bio-active agents |
| 07/29/2014 | US8790696 Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures |
| 07/29/2014 | US8790695 Medicinal carriers, and preparation method and uses thereof |
| 07/29/2014 | US8790693 Aqueous polymer dispersion based on N,N-diethylaminoethyl methacrylate, its preparation and use |
| 07/29/2014 | US8790692 Break resistant gel capsule |
| 07/29/2014 | US8790691 Modified drugs for use in liposomal nanoparticles |
| 07/29/2014 | US8790690 Patch and patch preparation |
| 07/29/2014 | US8790689 Tamper resistant transdermal dosage form |
| 07/29/2014 | US8790686 Method and composition for treating hemorrhoids |
| 07/29/2014 | US8790685 Bioadhesive gel based on hydroxyethylcellulose |
| 07/29/2014 | US8790679 Intracutaneous paste composition |
| 07/29/2014 | US8790678 Biomaterials having nanoscale layers and coatings |
| 07/29/2014 | US8790667 Surface immobilized chaperones |
| 07/29/2014 | US8790666 Nerve construct containing living stretch-grown nervous tissue |
| 07/29/2014 | US8790655 Conjugates of synthetic TLR agonists and uses therefor |
| 07/29/2014 | US8790622 Cosmetic formulation containing a non water-soluble amphiphilic copolymer as thickening agent |
| 07/29/2014 | US8790621 Nanoparticles and nanoparticle compositions |
| 07/29/2014 | CA2806767C Patch and method for producing the same |
| 07/29/2014 | CA2662510C Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy |
| 07/29/2014 | CA2661819C Fixed combination dosage forms for the treatment of migraine |
| 07/29/2014 | CA2653537C Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic |
| 07/29/2014 | CA2652500C Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
| 07/29/2014 | CA2649870C Drug release from nanoparticle-coated capsules |
| 07/29/2014 | CA2646942C Improved snuff composition |
| 07/29/2014 | CA2644429C Bioresorbable controlled-release composition |
| 07/29/2014 | CA2621273C Stable pharmaceutical composition comprising a pyrimidine-sulfamide |
| 07/29/2014 | CA2611724C Stabilized milnacipran formulation |
| 07/29/2014 | CA2608631C Method and composition for treating inflammatory disorders |
| 07/29/2014 | CA2606933C Steroid kit and foamable composition and uses thereof |
| 07/29/2014 | CA2601755C Melt granulation of a composition containing a calcium-containing compound |
| 07/29/2014 | CA2540539C A mixture for transdermal delivery of low and high molecular weight compounds comprising an ethoxylated oil |
| 07/29/2014 | CA2494974C Il-7 drug substance, composition, preparation and uses |
| 07/25/2014 | CA2840584A1 Hydrogel filled barbed suture |
| 07/24/2014 | WO2014113693A1 Modified release osmotic pump for ph-responsive intravaginal drug delivery |
| 07/24/2014 | WO2014113576A1 Needleless injection device and methods of administering one or more needleless injections to an organ of interest |
| 07/24/2014 | WO2014113377A1 Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant |
| 07/24/2014 | WO2014113358A1 Lyophilization process |
| 07/24/2014 | WO2014113260A1 Androgen receptor modulator and uses thereof |
| 07/24/2014 | WO2014111812A1 All direction stretchable dressing article associated with curable materials |
| 07/24/2014 | WO2014111790A2 Stable transdermal pharmaceutical drug delivery system comprising rivastigmine |
| 07/24/2014 | WO2014111737A1 Composition for increasing of the effectiveness of uv-b therapy, process for the preparation thereof, and its use |
| 07/24/2014 | WO2014111254A1 Composition of tiacumicin compounds |
| 07/24/2014 | WO2014076568A3 Pharmaceutical compositions of cetp inhibitors |
| 07/24/2014 | WO2014057432A3 Multicomponent lipid nanoparticles and processes for the preparation thereof |
| 07/24/2014 | WO2013174774A3 Cosmetic compositions comprising magnetosomes and uses thereof |
| 07/24/2014 | WO2013096811A3 Transmucosal drug delivery devices for use in chronic pain relief |
| 07/24/2014 | WO2013006795A3 Antiviral compositions and methods of their use |
| 07/24/2014 | WO2012145460A3 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents |
| 07/24/2014 | US20140206759 Process for the production of biodegradeable, functionalised polymer particles, and use thereof as pharmaceutical supports |
| 07/24/2014 | US20140206742 Pharmaceutical composition with improved bioavailability |
| 07/24/2014 | US20140206737 Application of Clonidine Hydrochloride as an Information Intervention Agent and an Information Intervention Product and the Method of Making the Same |
| 07/24/2014 | US20140206717 Use of inorganic matrix and organic polymer combinations for preparing stable amorphous dispersions |
| 07/24/2014 | US20140206709 Certain amino-pyrimidines, compositions thereof, and methods for their use |
| 07/24/2014 | US20140206692 Oral formulations of kinase inhibitors |
| 07/24/2014 | US20140206659 Tazobactam arginine antibiotic compositions |
| 07/24/2014 | US20140206641 Remedy |
| 07/24/2014 | US20140206638 Pulmonary delivery of aminoglycoside |
| 07/24/2014 | US20140206636 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 07/24/2014 | US20140206626 Methods of providing therapeutic effects using cyclosporin components |
| 07/24/2014 | US20140206615 Glp-1 agonist and cardiovascular complications |
| 07/24/2014 | US20140206614 Compositions for Achieving a Therapeutic Effect in an Anatomical Structure |